Quince Therapeutics (QNCX) Stock Erupts 300% as Buyout Rumors Emerge

TLDR Quince Therapeutics (QNCX) shares surged over 300% Tuesday after the company hired LifeSci Capital to review strategic options The biotech firm is exploring partnerships, mergers, acquisitions, and licensing deals to maximize shareholder value Trading volume hit 1.1 billion shares as investors speculated on a potential buyout at a premium price Quince develops bone-targeted drug [...]

The post Quince Therapeutics (QNCX) Stock Erupts 300% as Buyout Rumors Emerge appeared first on Blockonomi.